Unknown

Dataset Information

0

Promoter methylation of yes-associated protein (YAP1) gene in polycystic ovary syndrome.

ABSTRACT: DNA methylation modification has been proved to influence the phenotype of polycystic ovary syndrome (PCOS). Genome-wide association studies (GWAS) demonstrate that yes-associated protein (YAP1) genetic sites are associated with PCOS. The study aims to detect the methylation status of YAP1 promoter in ovary granulosa cells (GCs) of PCOS patients and explore novel therapeutic targets for PCOS.Randomized controlled trial was applied and a total of 72 women were included in the study, including 36 cases of PCOS patients and 36 cases of health controls. Ovary GCs were extracted from in vitro fertilization embryo transfer. Methylation status of YAP1 promoter was detected by bisulfite sequencing PCR (BSP). Protein and mRNA expression of YAP1 were measured by western blotting and real-time quantitate PCR.Overall methylation level of YAP1 promoter region from PCOS group was significantly lower than that from control group. CpG sites analysis revealed that 12 sites (-443, -431, -403, -371, -331, -120, -49, -5, +1, +9, +15, +22) were significantly hypomethylated in women with PCOS (P?

SUBMITTER: Jiang LL 

PROVIDER: S-EPMC5266164 | biostudies-literature | 2017 Jan

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Promoter methylation of yes-associated protein (YAP1) gene in polycystic ovary syndrome.

Jiang Li-Le LL   Xie Juan-Ke JK   Cui Jin-Quan JQ   Wei Duo D   Yin Bao-Li BL   Zhang Ya-Nan YN   Chen Yuan-Hui YH   Han Xiao X   Wang Qian Q   Zhang Cui-Lian CL  

Medicine 20170101 2

<h4>Background</h4>DNA methylation modification has been proved to influence the phenotype of polycystic ovary syndrome (PCOS). Genome-wide association studies (GWAS) demonstrate that yes-associated protein (YAP1) genetic sites are associated with PCOS. The study aims to detect the methylation status of YAP1 promoter in ovary granulosa cells (GCs) of PCOS patients and explore novel therapeutic targets for PCOS.<h4>Methods</h4>Randomized controlled trial was applied and a total of 72 women were i  ...[more]

Similar Datasets

Unknown Association between single nucleotide polymorphisms, TGF-β1 promoter methylation, and polycystic ovary syndrome.
| S-EPMC10759533 | biostudies-literature
Unknown Quantitative methylation level of the EPHX1 promoter in peripheral blood DNA is associated with polycystic ovary syndrome.
| S-EPMC3914883 | biostudies-literature
Unknown Genetic variation in the Mcp-1 gene promoter associated with the risk of polycystic ovary syndrome.
| S-EPMC4406762 | biostudies-literature
Unknown An interleukin-6 gene promoter polymorphism is associated with polycystic ovary syndrome in South Indian women.
| S-EPMC3843174 | biostudies-literature
Transcriptomics Role of Yes-Associated Protein 1 (YAP1) in rhabdomyosarcoma
2014-08-12 | E-GEOD-47198 | biostudies-arrayexpress
Unknown Role of Single Nucleotide Variants in the <i>YAP1</i> Gene in Adolescents with Polycystic Ovary Syndrome.
| S-EPMC9312887 | biostudies-literature
Unknown Analysis of Yes-Associated Protein-1 (YAP1) Target Gene Signature to Predict Progressive Breast Cancer.
| S-EPMC8999906 | biostudies-literature
Transcriptomics Role of Yes-Associated Protein 1 (YAP1) in rhabdomyosarcoma
2014-08-12 | GSE47198 | GEO
Unknown Genome-wide DNA methylation and gene expression patterns provide insight into polycystic ovary syndrome development.
| S-EPMC4196149 | biostudies-literature
Unknown FTO and MC4R gene variants are associated with obesity in polycystic ovary syndrome.
| S-EPMC3024473 | biostudies-literature